Skip to main content
Premium Trial:

Request an Annual Quote

Eurobio Scientific to Commercialize CirrusDx Molecular Biology Instrument in France, North Africa

NEW YORK – French in vitro diagnostics firm Eurobio Scientific said on Monday it has reached a deal with CirrusDx to commercialize its molecular biology platform, T-COR 8, in France and in the Maghreb countries of North Africa.

Financial and other terms of the deal were not disclosed. The Maghreb countries include Algeria, Libya, Mauritania, Morocco, Tunisia, and Western Sahara.

T-COR 8 is a real-time PCR thermocycler originally developed for the US Army and offered by Tetracore Group. CirrusDx, headquartered in Rockville, Maryland, is the commercial arm of Tetracore. The instrument is highly compact and mobile and can be used for emergency or decentralized applications at the point of care, Eurobio said in a statement.

The company added that T-COR 8 is designed to run assays individually in real time and has eight independent wells, allowing for the simultaneous analyses of up to eight patient samples.

Paris-based Eurobio said it will develop a new range of proprietary products for the T-COR 8 instrument, which will complement the EurobioPlex suite of tests already available for use with Seegene's high-speed multiplex platform.

The new kits will include tests for detecting pathogens, including those for infectious diseases such as meningitis (viruses and bacterial) and viral diseases including Dengue fever. Eurobio plans to pursue CE-IVD marking for the new tests. It added that five kits have been CE-marked and plans to get such designation for 15 other tests.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.